Your browser doesn't support javascript.
loading
Sequencing-based microsatellite instability testing using as few as six markers for high-throughput clinical diagnostics.
Gallon, Richard; Sheth, Harsh; Hayes, Christine; Redford, Lisa; Alhilal, Ghanim; O'Brien, Ottilia; Spiewak, Helena; Waltham, Amanda; McAnulty, Ciaron; Izuogu, Osagie G; Arends, Mark J; Oniscu, Anca; Alonso, Angel M; Laguna, Sira M; Borthwick, Gillian M; Santibanez-Koref, Mauro; Jackson, Michael S; Burn, John.
Afiliação
  • Gallon R; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Sheth H; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Hayes C; FRIGE's Institute of Human Genetics, FRIGE House, Ahmedabad, India.
  • Redford L; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Alhilal G; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • O'Brien O; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Spiewak H; Northern Genetics Service, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Waltham A; Northern Genetics Service, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • McAnulty C; Northern Genetics Service, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Izuogu OG; Northern Genetics Service, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Arends MJ; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Oniscu A; Division of Pathology, Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Alonso AM; Department of Molecular Pathology, Laboratory Medicine, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
  • Laguna SM; Oncogenetics and Hereditary Cancer Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad Pública de Navarra (UPNA), Pamplona, Spain.
  • Borthwick GM; Oncogenetics and Hereditary Cancer Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad Pública de Navarra (UPNA), Pamplona, Spain.
  • Santibanez-Koref M; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Jackson MS; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Burn J; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Hum Mutat ; 41(1): 332-341, 2020 01.
Article em En | MEDLINE | ID: mdl-31471937

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Marcadores Genéticos / Testes Genéticos / Repetições de Microssatélites / Predisposição Genética para Doença / Instabilidade de Microssatélites / Ensaios de Triagem em Larga Escala Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Hum Mutat Assunto da revista: GENETICA MEDICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Marcadores Genéticos / Testes Genéticos / Repetições de Microssatélites / Predisposição Genética para Doença / Instabilidade de Microssatélites / Ensaios de Triagem em Larga Escala Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Hum Mutat Assunto da revista: GENETICA MEDICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido